ANTONY, France, Dec. 5, 2013—SpineVision®, a commercial-stage medical device company that designs, develops and markets products for the surgical treatment of spine disorders, announced today that it has: (1) expanded its Flex+2™ dynamic stabilization platform offerings with the addition of the prebent Flex+™2 for use in hybrid cases; and, (2) received regulatory approval to market its Flex+2™ products in Brazil.
Earlier this year, SpineVision® started selling its new-generation Flex+2TM dynamic and hybrid stabilization rod in Europe. In addition, 510(k) approval has been granted in the United States for a range of surgical instrumentation focused on a minimally invasive approach to treating conditions related to aging and degeneration of the spine.
“We are extremely pleased with the expansion of our product offerings and with the number of markets in which we have now established a considerable sales presence. These factors are driving our double-digit sales growth. Not only are we selling our products in the U.S. and Europe, but also we now are broadening our product offerings and presence in South America and especially Brazil, where there is significant opportunity for SpineVision,” said Arnaud Brisard, CEO.
“We are making the most out of the cash infusion we announced earlier this year, when we raised $10 million from new and existing investors for expansion of commercial operations in the U.S. market as well as for growing commercial activities in Europe and South America,” added Brisard. “We believe that SpineVision is strongly positioned to continue double-digit expansion of sales in 2014.”
About SpineVision®
SpineVision® is a privately owned, integrated spinal technology company focused on development and marketing of implants and instrumentation for spinal treatment. The company designs innovative products that offer key advantages to surgeons and benefits to patients. SpineVision®’s current products offer solutions for approximately 90% of spinal pathologies: i.e. lumbar degenerative disc diseases, deformities, cervical disorders, trauma and tumors. With its new-generation products Flex+2TM and LUMISTM, SpineVision® is the only manufacturer offering a dynamic stabilization system that can be used in a percutaneous approach. The Company is headquartered in Antony (south of Paris), France, and has subsidiaries in Belgium, Germany, Italy, UK and the USA.